1[1]The national institute of neurological disorders and stroke rt-pa stroke study group.Anonymous tissue plasminogen activitor for acute ischemic stroke[J].N Engl J Med ,1995;333(24):1581
2[2]Hacke W,Kaste M,Fieschi C, et al.Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke.the European cooperative acute stroke study(ECASS)[J].JAMA,1995;274(13):1017
3[3]Albers GW,Bates VE,Clark WM,et al.Intravenous tissue-type plasminogen for treatment of acute stroke:the standard treatment with alteplase to reverse stroke(STARS)study[J].JAMA,2000;283(9):1145
5[5]Schulling S,Grond M,Rudolf,et al.One-year follow-up in acute stroke patients treated with rtPA in clinical routine[J].Stroke,2000;31:1552
6[6]Alexandrov AV,Demachuk AM,Fellerg RA,et al.High rate of complete recanalization and dramatic clinical recovery during doppler monitoring[J].Stroke,2000;31(3):610
7[7]Kaufmann AM,Andrew D,Firlik AD,et al.Ischemic core and penumbra in human stroke[J].Stroke,1999;30:93
8[8]Abers W.Expanding the window for thrombolytic therapy in acute stroke[J].Stroke,1999;30:2230
9[9]Karonen JO,Vanninen RL,Liu Y,et al.Combined diffusion and perfusion MRI with correlation to single-photon emission CT in acute ischemic stroke[J].Stroke,1999;30:1583
10[10]Demchuk AM,Morgenstern LB,Krieger DW,et al.Serum glucose level and diabetes predict tissue plasminogen activator-related intra cerebral hemorrage in acute ischemic stroke[J].Stroke,1999;30:34
